Telepathology and digital pathology, enhanced with artificial intelligence (AI), represent groundbreaking technology advancements. These entities offer information exchange, enhanced teaching and research, and automated diagnosis with high precision through a computerized approach. Machine learning in pathology shows promise for both human and veterinary medicine, yielding favorable results and in some cases, surpassing the accuracy of human pathologists. This study aimed to highlight the significance of integrated AI with telepathology and digital pathology, outlining both its advantages and limitations while emphasizing the crucial role of pathologists in its implementation. A literature review was conducted to uncover publications and data on telepathology and AI, and their implementation in human and veterinary medicine. This approach has facilitated information exchange, enhancing both teaching and research. In addition, it facilitates the creation of innovative methods and offers more precise patient diagnoses, adhering to ethical and legal standards. This study delivers valuable and comparable data on telepathology, digital pathology, and AI integration. Given the continually emerging nature of these technologies, further studies are essential for their application to human and veterinary medicine. Keywords: artificial intelligence, diagnosis, telepathology.

The giant anteater (Myrmecophaga tridactyla) is a vulnerable species from Central and South America, and is considered possibly extinct in Belize, Guatemala, El Salvador, and Uruguay. Due to the species’ conservation and reproductive importance, this research aimed to characterize the morphology, histochemical, immunohistochemical, and ultrastructural feature of the giant anteater prostate gland. For this, we collected 11 giant anteater prostate glands and performed macroscopic, morphological, histochemical, immunohistochemical, and ultrastructural analysis. Nine prostate glands from an adult subject and two from young subjects were studied. Grossly, the adult giant anteater prostate gland is divided in two distinct zones; the central zones (composed mainly of ducts) and the peripheral zones (of acini formed by secretory cells). The secretory cells showed positive periodic acid–Schiff staining. Furthermore, the immunohistochemical characterization revealed a similar human prostate pattern, with p63 staining basal cells, uroplakin III (UPIII) superficial cells of prostatic urethra, androgen receptor (AR) expressing nucleus of secretory and stromal cells, and prostatic specific antigen (PSA) staining prostatic epithelial cells. Overall, our research provided an in-depth morphological description of the giant anteater’s prostate gland, providing valuable information for futures studies focused on giant anteater conservation.

Splenic tumors are very common in dogs, and canine hemangiosarcoma (HSA) is one of the most important malignant splenic tumors. Surgery followed by chemotherapy (anthracycline-based protocols) is recommended for treating canine HSA; however, patients still do not achieve long-term survival. Therefore, this research aimed to assess vascular endothelial growth factor receptor-2 (VEGFR-2) and platelet-derived growth factor receptor-β (PDGFR-β) gene expression in formalin-fixed tissues, evaluate the quality of mRNA for quantitative polymerase chain reaction (qPCR) analysis and identify drug repositioning candidates based on VEGFR-2 and PDGFR-β. qPCR analysis identified the relative expression of heterogeneous VEGFR-2 and PDGFR-β, with samples showing no transcripts or very low expression and those with higher relative quantification for both genes. We then used immunohistochemistry to correlate the relative quantification of VEGFR-2 and PDGFR-β transcripts with respective higher protein expression to validate our results. In the next step, we evaluated drug repositioning candidates and identified small molecule inhibitors (i.e. sorafenib) and natural compounds (curcumin and resveratrol) with the ability to block VEGFR-2 and PDGFR-β genes. Overall, our results indicated that VEGFR-2 and PDGFR-β expression is highly variable among canine HSA samples and different drugs can block the expression of both genes. Therefore, a personalized approach could be useful for selecting anti-VEGFR-2 and PDGFR-β therapies and both genes are potential candidates for future oncological panels. Os tumores esplênicos são muito comuns em cães, e o hemangiosarcoma (HSA) é um dos tumores esplênicos malignos mais importantes em cães. A cirurgia seguida de quimioterapia (protocolos baseados em antraciclinas) é a abordagem terapêutica mais recomendada para o tratamento da HSA canino; no entanto, os pacientes ainda não alcançam longa sobrevida após tratamento. Portanto, esta pesquisa teve como objetivo avaliar a expressão do receptor do fator de crescimento endotelial vascular-2 (VEGFR-2) e do receptor do fator de crescimento derivado de plaquetas-β (PDGFR-β) em tecidos fixados em formalina e identificar candidatos ao reposicionamento de medicamentos baseado na expressão desses genes. A análise qPCR identificou a expressão relativa heterogênea de VEGFR-2 e PDGFR-β, com amostras sem transcritos ou com expressão muito baixa ou amostras com alta quantificação relativa para ambos os genes. Em seguida, foi realizada o exame imuno-histoquímico para correlacionar a quantificação relativa dos transcritos de VEGFR-2 e PDGFR-β com a respectiva maior expressão proteica para validar nossos resultados. Na próxima etapa, avaliamos candidatos ao reposicionamento de medicamentos e identificamos inibidores de moléculas pequenas (ou seja, sorafenibe) e compostos naturais (curcumina e resveratrol) com capacidade de bloquear os genes VEGFR-2 e PDGFR-β. No geral, nossos resultados indicaram que a expressão de VEGFR-2 e PDGFR-β é altamente variável entre amostras caninas de HSA e diferentes drogas podem bloquear a expressão de ambos os genes. Portanto, uma abordagem personalizada poderia ser útil para selecionar terapias anti-VEGFR-2 e PDGFR-β e ambos os genes são potenciais candidatos para futuros painéis oncológicos.

Objective This study aimed to evaluate hematologic, biochemical, and gasometric parameters in Wistar rats to better understand brain death parameters and reduce early misdiagnoses. Methods Fifteen adult male Wistar rats (Rattus norvergicus; HanUnib: WH) were randomly distributed into three groups of five animals: the control group (G0) with evaluation performed before brain death, and two groups (G1 and G2) with brain death induced at different times: immediately after induction (G1) and one hour after induction (G2). Venous and arterial blood samples were taken to perform complete blood count, biochemical, and blood gas assays. Samples were taken at specific times based on the group each rat belonged to. Results Statistically significant mean values were observed (PG2 and G0>G2), monocytes (G2>G1 and G0>G1), creatinine (G2>G0), aspartate aminotransferase (G1>G0), potassium (G2>G0), and bicarbonate (G0>G1). Discussion Furthermore, brain death showed a unique response in each organism, complicating its precise determination even more.

Background and Aim: Biobanks represent organized repositories of biological samples linked to associated data, designed for long-term scientific, clinical, and forensic utilization. In veterinary medicine, animal biobanks facilitate biomedical research, genetic resource preservation, species conservation, and forensic investigations. The present systematic review aimed to synthesize advances, persistent challenges, and practical applications of biobanks in veterinary forensic medicine, with particular emphasis on their contribution to detection, investigation, and suppression of wildlife trafficking. Materials and Methods: A systematic literature search was conducted across Periódicos Capes, PubMed, SciELO, and ScienceDirect databases, covering publications from 2013 to 2023. Search strings combined terms such as “animal biobank”, “animal biorepository”, “wildlife forensic”, “wildlife trafficking”, and “forensic veterinary” (English), together with Portuguese equivalents. Only peer-reviewed articles published in English or Portuguese that explicitly addressed biobanks in veterinary forensic contexts or wildlife crime were included. The review adhered to PRISMA 2020 guidelines. Screening involved title/abstract evaluation followed by full-text assessment. Data were narratively synthesized. Results: Of 1,495 records identified, 15 studies fulfilled all inclusion criteria after exclusion of 1,460 irrelevant or non-qualifying publications. No eligible articles appeared between 2013 and 2014. From 2015 onward, publications demonstrated progressive refinement, transitioning from molecular barcoding for species identification toward integrated applications in geographic origin assignment, chain-of-custody documentation, and evidentiary support in judicial proceedings. Key materials included DNA from muscle, scales, claws, and feathers; cryopreserved gonadal tissues; and somatic cells derived from minimally invasive sources (e.g., feather follicles) or roadkill specimens. Studies highlighted particular utility in identifying fraudulently labeled fishery products, counterfeit mammalian derivatives (e.g., fake tiger claws), and confiscated pangolin scales, as well as in tracing trafficking routes in high biodiversity regions. Conclusion: Veterinary forensic biobanks offer substantial potential for accurate species and geographic provenance determination, thereby strengthening enforcement against illegal wildlife trade. Nevertheless, implementation remains constrained by absent standardized operating procedures, limited practitioner awareness, fragmented reference databases, inadequate inter-institutional connectivity, and elevated logistic/financial demands. Regionalized biobanks integrated with wildlife screening centers (CETAS), harmonized chain-of-custody protocols, and artificial intelligence-supported data curation are proposed as priority strategies to translate existing scientific advances into routine forensic and conservation practice. Keywords: artificial intelligence, biodiversity conservation, biobank, conservation genetics, DNA barcoding, forensic applications, genetic resource preservation, illegal trade monitoring, One Health, species identification, veterinary forensic medicine, wildlife screening centers, wildlife trafficking.

Neoplastic diseases are the leading cause of death in animals and humans worldwide. Furthermore, neoplasms in patients with infectious diseases account for 15% of non-hereditary neoplasms. Chronic infections are considered a major cause of neoplasm development, with numerous mechanisms mediated by these factors reportedly involved in oncogenesis. This review aimed to identify publications involving diagnosis and prognosis to improve understanding of concomitant interrelated scenarios involving interactions between microorganisms and neoplasms. A systematic literature review was conducted to identify publications regarding effects of infectious agents on neoplasms, including diagnostic challenges, and impacts on patient prognosis. Coexistence of neoplasms and infectious diseases has been frequently reported. Microorganisms can promote or suppress neoplastic development, with studies conducted to elucidate interactions between microorganisms and oncogenesis. Understanding the role of pathogens in oncogenesis could help prevent or control pathogen transmission and, consequently, the incidence of certain cancers, with much relevance for public health.